Artelo Biosciences Inc (ARTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,198 | 10,273 | 600 | 1,720 | 2,066 |
| TOTAL | $4,371 | $10,421 | $695 | $1,827 | $2,233 |
| Non-Current Assets | |||||
| Intangibles | 2,039 | 2,039 | 2,039 | 2,364 | 2,039 |
| Other Non-Current Assets | 49 | 58 | 67 | 76 | 85 |
| TOTAL | $2,088 | $2,097 | $2,106 | $2,440 | $2,124 |
| Total Assets | $6,459 | $12,518 | $2,801 | $4,267 | $4,357 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,413 | 4,509 | 3,380 | 3,900 | 4,867 |
| Accrued Expenses | N/A | 36 | 15 | 46 | 18 |
| Other current liabilities | N/A | 582 | N/A | N/A | N/A |
| TOTAL | $1,455 | $5,828 | $4,044 | $4,860 | $5,712 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 7 | 18 | 29 | 40 | 51 |
| TOTAL | $7 | $18 | $29 | $40 | $51 |
| Total Liabilities | $1,462 | $5,846 | $4,073 | $4,900 | $5,763 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,595 | 2,334 | 708 | 673 | 440 |
| Common Shares | 4 | 1 | 1 | 2 | 1 |
| Retained earnings | -68,400 | -65,973 | -63,015 | -58,849 | -55,729 |
| Other shareholders' equity | -242 | -246 | -272 | -277 | -295 |
| TOTAL | $4,997 | $6,672 | $-1,272 | $-633 | $-1,406 |
| Total Liabilities And Equity | $6,459 | $12,518 | $2,801 | $4,267 | $4,357 |